Starting Your Patient on Ilumya? A Simple Guide for Quick Access

Shannon E. Epling MSc, Pharmaceutical Sciences Date: 07/11/2024

Skip the reading:

Ilumya Enrollment Forms   


Ilumya (tildrakizumab-asmn) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a human monoclonal antibody that targets the interleukin-23 (IL-23) receptor and works by blocking the action of IL-17A, a cytokine that plays a key role in the development of psoriasis.

However, obtaining access to enrollment forms can be time-consuming and confusing. In this article, we will provide you with access to Ilumya enrollment forms and introduce you to Ilumya support programs – which provide a variety of HCP and patient resources to streamline the process of prescribing.

Download Ilumya Enrollment Forms

Get  Ilumya enrollment forms to get your patients started on treatment.

Accessing Ilumya Enrollment Forms

To obtain Ilumya enrollment forms, you can download the PDF available here. Providers can also visit the Ilumya Website or contact a Ilumya representative directly at  (855-445-8692).  

Once you have obtained and accurately completed the Ilumya enrollment forms with your patient’s information, they can be submitted to the appropriate parties: faxed to (877-872-6575). Ilumya enrollment forms require information about your patient’s medical history, insurance coverage, and the reason for prescribing Ilumya. Following submission, the process of securing approval for Ilumya can take several days to a few weeks.

Ilumya Support® Program

Ilumya Support® is a patient support program offered by the manufacturer of Ilumya. The program is designed to provide resources and support to patients who have been prescribed Ilumya, including financial assistance, education, and ongoing support throughout their treatment. You can enroll your patient in the Ilumya Support® program via the aforementioned enrollment forms. 

Some of the benefits of the Ilumya Support® Program include:

  • Enrollment support: Ilumya representatives are available to help healthcare providers and patients navigate the enrollment process and answer any questions they may have.
  • Financial assistance: The program offers financial support to eligible patients, including co-pay assistance, reimbursement support, and free medication for qualifying patients who are uninsured or underinsured.
  • Treatment support: Ilumya Support® offers ongoing support throughout a patient's treatment journey, including reminders and personalized resources to help patients stay on track with their medication.
  • Patient Education: The program provides patient education materials, including a patient brochure and website, to help patients understand the risks and benefits of Ilumya, how to properly administer the medication, and what to expect during treatment.

Overall, these patient support programs aim to provide comprehensive support for patients who are prescribed Ilumya, ensuring they have access to the medication, receive proper training and support, and have resources available to help them manage their condition.

Conclusion 

As a healthcare provider, it can be challenging and time-consuming to navigate access to Ilumya enrollment forms. With the aid of the Ilumya Support® Program and PrescriberPoint, you can gain access to resources and support to help streamline the process of prescribing to ensure that your patients receive the medications they need, when they need them. By utilizing the resources available through the program, you can confirm that your patients receive the best possible care for their autoimmune disorders.

PRESCRIBERPOINT INSIGHTS

Get the latest insights delivered to your inbox

Explore our blog

Need Support? Get in touch